Pain Management
Conditions
Interventions
Group 1:0.3% ropivacaine group
Group 2:0.3% ropivacaine +0.5 g/kg DMG group
Sponsors
Shiyan People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. The patients who are scheduled to undergo laparoscopic cholecystectomy; 2. Patients aged 18-65 years; 3. Patients with ASA grade I-II had no serious cardiopulmonary disease, normal liver and kidney function, and no mental system disease before operation; 4. Patients with body mass index (BMI) of 18-28kg / m2; 5. All patients signed informed consent.
Exclusion criteria
Exclusion criteria: 1. No accompanying or guardian; 2. Uncontrolled patients with severe hypertension, serious arrhythmia and unstable angina; 3. Patients with liver dysfunction (above child Pugh C level); 4. Patients with severe renal dysfunction (CR clearance rate < 30 ml / min); 5. Patients with abnormal hearing and vision unable to communicate; 6. Patients with neuromuscular diseases; 7. Patients who are allergic to drugs or who are allergic to drugs or have other contraindications; 8. Patients who have participated in additional drug clinical trials in the past 30 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS pain score;Ramsay sedation score;Levels of inflammatory cytokines;stress reaction; | — |
Countries
china
Contacts
Public ContactYun Xiao
Postgraduate training base of Hubei Medical College of Jinzhou Medical University
Outcome results
None listed